Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
1(25.0%)
Early Phase 1
1(25.0%)
4Total
N/A(2)
Phase 1(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00883402Not ApplicableActive Not Recruiting

Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients

Role: collaborator

NCT00129987Not ApplicableCompleted

Trial of Lay-led Individualised Self-management Education for Adults With Asthma

Role: collaborator

NCT01150084Early Phase 1Unknown

"Step by Step": A Feasibility Study of the Promotion of Lunchtime Walking to Increase Physical Activity and Improve Mental Well-being in Sedentary Employees

Role: collaborator

NCT00164749Phase 1Completed

A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease

Role: collaborator

All 4 trials loaded